Dendi

Dendi is a health care and information technology startup, established in 2018. The company's slogan "Software solutions to future-proof clinical laboratories" encapsulates their focus on providing a configurable LIS platform for clinical labs. The platform is designed to cater to various modalities including blood, toxicology, clinical chemistry, molecular, genomics, and esoteric testing.

What sets Dendi apart is its emphasis on connectivity. The platform's in-house integrations team ensures quick setup and maintenance of interfaces for instruments and analyzers, EHR/EMRs, billing service providers, and third-party services. This emphasis on connectivity positions Dendi as a comprehensive and flexible solution for high-volume and novel testing workflows.

The most recent funding round for Dendi took place on 17 August 2023, where the company secured a $1.60M investment in a Seed Round. This investment came from QuidelOrtho, underlining the confidence that investors in the health care and information technology sectors have in Dendi's platform and vision.

Overall, Dendi presents an intriguing opportunity for investors looking to get involved in the future of clinical laboratories through innovative software solutions and strong industry partnerships. With its recent funding and industry-focused approach, Dendi is well-positioned to make a significant impact in the evolving landscape of health care technology.